Creating new proteins using special amino acids
Engineering Proteins with Noncanonical Amino Acids
['FUNDING_OTHER'] · RICE UNIVERSITY · NIH-10765446
This study is exploring new ways to add special building blocks to proteins that could make them work better, with the goal of helping create new medicines and sensors for health.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | RICE UNIVERSITY (nih funded) |
| Locations | 1 site (HOUSTON, UNITED STATES) |
| Trial ID | NIH-10765446 on ClinicalTrials.gov |
What this research studies
This research focuses on developing innovative methods to incorporate noncanonical amino acids (ncAAs) into proteins, which can enhance their properties and functions. By engineering cells to biosynthesize these special amino acids, the project aims to create organisms that can produce bioactive drugs and in vivo sensors. The approach involves using advanced techniques in metabolic engineering and bioinformatics to identify and utilize new biosynthetic pathways for ncAAs. This could lead to significant advancements in how proteins are designed and used in medical applications.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with conditions that could benefit from novel drug therapies or diagnostic technologies derived from engineered proteins.
Not a fit: Patients who are not seeking new therapeutic options or who do not have conditions related to protein synthesis may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new therapeutic drugs and diagnostic tools that are more effective and tailored to specific medical needs.
How similar studies have performed: Other research has shown promise in using similar approaches to engineer proteins with enhanced functionalities, indicating a potential for success in this novel area.
Where this research is happening
HOUSTON, UNITED STATES
- RICE UNIVERSITY — HOUSTON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: XIAO, HAN — RICE UNIVERSITY
- Study coordinator: XIAO, HAN
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.